To avoid a messy, billion-dollar U.S. patent fight over CRISPR-Cas9, Chinese biotech startups are engineering proprietary DNA scalpels from scratch
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
In a lab in Changzhou, an industrial city in eastern China, researchers at agritech startup Wimi Biotechnology Co. Ltd. are doing something that sounds almost too simple: they “cut” a single stretch of corn DNA, let the plant repair itself, and wait to see what new trait emerges — higher yield, a shorter stalk, less water in the kernel.
To avoid a messy, billion-dollar U.S. patent fight over CRISPR-Cas9, Chinese biotech startups are engineering proprietary DNA…
Technique to precisely edit large DNA segments could transform disease research, crop breeding, experts say.
The policy push aims to cultivate ‘new quality productive forces’ in agriculture, boosting domestic biotech startups and paving…
Yoltech Therapeutics, one of China’s most prolific gene editing companies has raised its biggest round of funding ahead of plans…
AI gene editing factory allows rapid breeding of new plant varieties which taste better and are resistant to disease, say…
While a US company had earlier developed a similar AI-designed system for human cells, this is the first successful demonstration…
